Effects of 5-Aza-CdR on cell proliferation of breast cancer cell line MDA-MB-435S and expression of maspin gene

Abstract

The effects of 5-Aza-2’-deoxycytidine (5-Aza-CdR) on the proliferation of MDA-MB-435S cells and the expression of tumor suppressor gene maspin were investigated. Human breast cancer cell line MDA-MB-435S was treated with 5 μmol/L 5-Aza-CdR, a specific demethylating agent for 0 to 8 days. The growth of MDA-MB-435S cells was observed by MTT assay before and after 5-Aza-CdR treatment, respectively. The expression of maspin mRNA was detected by reverse transcription-polymerase chain reaction (RT-PCR). The cell cycle of MDA-MB-435S cells was analyzed by flow cytometry. The results showed that the growth of MDA-MB-435S cells treated with 5-Aza-CdR for 8 days was significantly suppressed as compared with the control groups, and the inhibition rate increased sharply from 5 day to 8 day (35.42% to 71.29%). Flow cytometry showed that 5 μmol/L 5-Aza-CdR could induce G₂/M cell cycle arrest and decrease the percentage of mitosis cell number in this cell line. Maspin mRNA was expressed in MDA-MB-435S cells after 5-Aza-CdR treatment, but it was weakly detectable before the treatment. It was concluded that Maspin gene might be transcriptional silencing by hypermethylation and the re-expression of maspin gene by 5-Aza-CdR can inhibit the proliferation and induce the G2/M arrest of MDA-MB-435S breast cancer cells.

Keywords

maspin / DNA methylation / 5-Aza-2’-deoxycytidine / breast cancer

References

[1] WeinbergR. A.. Oncogenes and tumor suppressor genes. CA Cancer J Clin, 1994, 44(3): 160-170

[2] GranderD.. How do mutated oncogenes and tumor suppressor genes cause cancer?. Med Oncol, 1998, 15(1): 20-26

[3] SzyfM., PakneshanP., RabbaniS. A.. DNA methylation and breast cancer. Biochem Pharmacol, 2004, 68(6): 1187-1197

[4] LockettJ., YinS., LiX., et al.. Tumor suppressive maspin and epithelial homeostasis. J Cell Biochem, 2006, 97(4): 651-660

[5] MercataliL., ValentiV., CalistriD., et al.. RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients. Ann Oncol, 2006, 17(3): 424-428

[6] OsborneC., WilsonP., TripathyD.. Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist, 2004, 9(4): 361-377

[7] OliveiraA. M., RossJ. S., FletcherJ. A.. Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. Am J Clin Pathol, 2005, 124(Suppl): S16-S28

[8] MunotK., BellS. M., LaneS., et al.. Pattern of expression of genes linked to epigenetic silencing in human breast cancer. Hum Pathol, 2006, 37(8): 989-999

[9] DulaimiE., HillinckJ., Ibanez de CaceresI., et al.. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res, 2004, 10(18Pt1): 6189-6193

[10] ShengS.. A role of novel serpin maspin in tumor progression: the divergence revealed through efforts to converge. J Cell Physiol, 2006, 209(3): 631-635

[11] ChenE. I., YatesJ. R.. Maspin and tumor metastasis. IUBMB Life, 2006, 58(1): 25-29

[12] BaileyC. M., Khalkhali-EllisZ., SeftorE. A., et al.. Biological functions of maspin. J Cell Physiol, 2006, 209(3): 617-624

[13] DokrasA., CoffinJ., FieldL., et al.. Epigenetic regulation of maspin expression in the human placenta. Mol Hum Reprod, 2006, 12(10): 611-617

[14] HerranzM., EstellerM.. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Methods Mol Biol, 2007, 361: 25-62

[15] Dolle L, Depypere H T, Bracke M E. Anti-invasive/anti-metastasis strategies: new roads, new tools and new hopes. Curr Cancer Drug Targets, 2006 (8):729–751